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INTRODUCTION 
Nausea and vomiting may occur independently of each other but generally  
are closely allied and  are presumed to be mediated by the same neural 
pathways, and so they be considered together.1,35 
Nausea denotes the feeling of an imminent desire to vomit, usually 
referred to throat or epigastrium. 
Vomiting or emesis refers to forceful oral expulsion of gastric contents. 
Retching denotes labored rhythmic contraction of respiratory and 
abdominal musculature that frequently precedes or accompanies vomiting. 
Nausea often precedes or accompanies vomiting .It is usually associated 
with diminished functional activity of stomach; that is hypotoxicity, 
hypoperistalisis, hyposecretion and altered small intestinal motility. 
(hypertoxicity, reversed peristalsis of duodenum) 
Often accompanying severe nausea is evidence of altered autonomic, 
especially parasympathetic activity such as skin pallor, increased perspiration, 
hypersalivation, Anorexia, defecation, occasionally hypotension and 
bradycardia (vasovagal syndrome). Nausea, retching, hypersalivation 
frequently precede the act of vomiting which is highly integrated sequence of 
involutary visceral and somatic motor events. 
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The stomach plays  a relatively passive role in the vomiting process, the 
major ejection force being provided by the abdominal musculature. 
With relaxation of gastric fundus and gastroesophageal sphincter, a sharp 
increase in the intraabdominal pressure is brought about by a forceful 
contraction of the diaphragm and abdominal wall muscles . This  together with 
concomitant annular contraction of gastric pylorus, results in the expulsion of 
gastric contents into the oesophagus. Increase intra thoracic pressure results in 
the further movement of  the oesophageal peristalsis which may play a role in 
this process. Reflex elevation of the pylorus during the vomiting act prevents 
the entry of the expelled material into the nasopharynx, whereas reflex closure 
of the glottis and inhibition of respiration help to prevent pulmonary 
aspiration. 
Orthognathic surgery  
The word “Orthognathic” comes from the greek word “ortho” meaning to 
straighten and “gnathia”  meaning jaw and thus orthognathic surgery means to 
straighten a jaw.41  
Orthognathic surgery is defined as the art and science of diagnosis, 
treatment planning and execution of  treatment to correct musculoskeletal 
dento-osseous  and soft tissue deformities of the jaws and associated 
structures.  
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It is the surgery to correct conditions of the jaw and face, related to 
structure, growth, sleep apnea, TMJ disorders or to correct orthodontic 
problems that cannot be easily treated with braces. Originally coined by         
Dr. Harold Hargis, D.M.D., it is also used in treatment of congenital 
conditions like cleft palate. Bones can be osteotomised and realigned, held in 
place with plates and screws. 
The surgery might involve one jaw or both jaws during the same 
procedure. The modification is done by making osteotomies in the bones of 
the mandible and / or maxilla and repositioning the osteomised segments in 
the desired alignment. Usually surgery is done under general anaesthesia 
performing nasotracheal intubation. This is to allow intermaxillary fixation 
during the surgery. The surgery often does not involve incising the skin by 
extra oral approach, instead the surgeon is often able to use an intraoral 
approach. 
Osteotomy refers to  simple bone cut. Whereas, ostectomy means the 
removal of portion of bone. The fundamental biology  behind the orthognathic 
surgery is that maxillary and mandibular bones are intraorally sectioned  and 
repositioned at  the desired site to correct dentofacial deformity. Various 
maxillary osteotomies performed include lefort I, lefort II, lefort III, anterior 
maxillary osteotomy, posterior maxillary osteotomy. Commonly performed 
mandibular osteotomies include bilateral saggital split osteotomy, subapical 
osteotomy, genioplasties and body osteotomies.  
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Undoubtedly orthognathic surgery is associated with many complications, 
one of which and most distressing to the patient is postoperative nausea and 
vomiting. 
Though Postoperative nausea vomiting is not life threatening, it can be 
quite distressing for the patient and often considered a “big little problem”.21 
Causative factors have been categorized into surgical, anesthetic, non 
anesthetic and postoperative factors 1. A number of factors have emerged 
which are associated with the problem. These include age, sex, history of 
motion sickness, previous PONV, vertigo or migraine, smoking status, type of  
volatile anaesthesia duration, type of surgery, pre anesthetic medication, the 
use of opiates, early postoperative ambulation, timing of oral intake, 
postoperative pain and use of postoperative analgesic drugs. There are infinite 
number of permutations that may lead to an unfavorable outcome. 
It is also important to take cognizance of these factors in the design of the 
study of PONV to avoid bias. 
Repeated emesis may have deleterious effects in  a number of ways. The 
process of vomiting if forceful may lead to pressure rupture of oesophagus or 
to linear mucosal tears in the region of cardio-oesophageal junction with 
resulting hematemesis. Prolonged vomiting may lead to dehydration, loss of 
gastric secretion resulting in metabolic alkalosis with hypokalemia. Gastric 
contents may be aspirated into the lungs resulting in aspiration pneumonitis.  
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Apart from medical complications, PONV have psychological effects that 
may result in patient experiencing anxiety about undergoing further surgery. 
Numerous modalities including identifying the risk factors in patients, 
variation in anaesthetic technique, prophylactic antiemetic administration have 
been used in an effort to decrease the incidence of PONV.  
 
Hypotensive anesthesia 
The deliberate induction and maintenance of intraoperative hypotension 
are adjuncts  for major maxillofacial orthognathic surgery. This is particularly 
true for procedures involving the  midfacial skeleton or harvesting of cranial 
bone. Deliberate reduction of blood pressure is common for neurovascular and 
orthopaedic surgery, and techniques learned have been applied to patients 
undergoing orthognathic surgery. The three principle benefits of hypotensive 
anaesthesia are reduction of intraoperative blood loss, improved visibility in 
the surgical field and reduced operative time 41. The principle of hypotensive 
anaesthesia is to maintain the balance  between the functions of the 
cardiorespiratory, metabolic, renal, endocrine and central nervous system 
functions and protect against irreversible changes in these organ systems35 
Sodium nitroprusside (SNP)  and nitroglycerin (NTG)  are often used for 
hypotensive anaesthesia because they are potent vasodilators with predictable, 
shortacting and easily reversible effects. A significant reduction in blood loss  
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and an improvement in the quality of the surgical field have been achieved 
with controlled hypotensive anaesthesia induced using SNP or NTG. 
Prolonged hypotensive anesthesia can present with various complications. The 
brain , heart , kidneys and liver are the organs most vulnerable to ischemia 
when blood flow is below critical level. Another organ susceptible to problems 
during hypotensive anesthesia is skin. This can explain the disturbingly 
common occurance of ischemic damage to nasal ala from tube pressure.41 
PATHOPHYSIOLOGY OF EMESIS 
Vomiting Mechanism :  
The act   of vomiting is under the control of two functionally distinct 
medullary centres : 35 the vomiting center in the dorsal portion of the lateral 
reticular formation and the chemoreceptor trigger zone in the  area postrema of 
the floor of the fourth ventricle. The vomiting centre controls and integrates 
the actual act of emesis. It receives afferent stimuli from the gastrointestinal  
tract and the other  parts of the body, from higher brainstem and cortical 
centres, especially the labyrinthine apparatus, and from the chemoreceptor 
trigger zone. Persons vary considerably in the threshold of their  vomiting 
center to different stimuli, The important efferent pathways in vomiting are the 
phrenic nerves (to the diaphragm), the spinal nerves (to the intercostals and 
abdominal musculature) and visceral efferent fibers in the vagus nerve (to the 
larynx, pharynx, esophagus and  stomach). The vomiting centre is located near 
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other medullary centres regulating respiratory, vasomotor and autonomic 
functions that may be involved  in the act of vomiting.  
The chemoreceptor  trigger zone by itself is incapable of mediating the act 
of vomiting; rather activation of this zone results in efferent impulses to the 
medullary vomiting centre, which in turn indicates emesis. The chemoreceptor 
trigger zone is emetic chemoreceptor that can be activated by a variety of 
stimuli or drugs, including apomorphine and other opiates, levodopa (after 
decarboxylation to dopamine), digitalis, bacterial toxins, radiation and 
metabolic abnormalities as occur with uremia and hypoxia.  
The chemoreceptor trigger zone (CTZ) is in, or near, the area postrema and 
contains high concentrations of opioid, dopamine, muscarinic, histamine, 
cholinergic, serotonin or 5-hydroxytryptamine (5-HT3) neurochemical 
receptors, and serves as a chemosensor.  
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MECHANISM OF NEUROTRANSMITTER SYSTEM OF PONV1 
VOMITING 
CENTER 
Vestibular apparatus 
(Cerbellum) Triggers : 
middle ear Surgery, movement 
after surgery and/or opioids 
Area Prostrema Chemoreceptior 
Trigger Zone (CTZ)Triggers: 
Inhalation agents, narcotics 
(opioids)Chemoreceptors : Blood borne 
emetics:  Dopamine, 
Serotonin,histamine, opioid acetylhidine 
Nucleus Tractus 
Solitarius 
Chemoreceptors : 
dopamine , serotonin, 
histamine, acetylcholine 
Vagal and Sympathetic 
Afferent Triggers :  
manipulation of the eyes 
Chemoreceptors :  
dopamine, histamine, 
opioids 
Glossopharyngeal and 
trigeminal afferents : 
glossopharyngeal nerve 
(eg. tonsillectomy) 
trigemino cardioreflex  
Stomach and intestine local 
irritants : Bacterias, viruses, 
cytotoxic drugs, radiation, GI 
tract irritants (eg. Blood in the 
stomach) beginning to eat after 
surgery 
Endocrine 
environmental triggers: 
female, gender, pregnancy 
Cerebral Cortex triggers : 
Fear, memory, emotions, stress, 
sights, smells, tastes 
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AIMS AND OBJECTIVES 
 
¾ To  evaluate  the incidence of postoperative nausea and vomiting after 
orthognathic surgery. 
 
¾ To identify the risk factors causing postoperative nausea and vomiting 
in patients undergoing orthognathic surgery under general anesthesia 
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REVIEW OF LITERATURE 
 
J.W. Dundee et al  (1975)16 The ability of cyclizine (50 mg) and 
perphenazine (2.5 and 5.0 mg) to counteract the emetic effects of pethidine 
(100 mg) and morphine (10 and 15 mg) was compared in women undergoing a 
standard minor operation with a standard anaesthetic.  Perphenazine (5.0 mg) 
was as effective an anti-emetic as cyclizine (50 mg) and both were more 
effective than perphenazine (2.5 mg). The reduction in vomiting and nausea 
by cycizine (50 mg) and perphenazine (5 mg) was approximately the same 
following pethidine (100 mg) and morphine (10 mg) but much less against the 
larger dose of morphine. Both anti-emetics had a rapid onset of action but their 
anti-emetic activity did not last as long as the emetic effect of morphine. 
Perphenazine (5 mg) was accompanied by an unacceptably high incidence of 
restlessness. In clinical practice cyclizine (50 mg) is preferred to perphenazine 
(5 mg) as an antiemetic. 
Carolyn M. Flanary et al (1983)7  The authors surveyed 93 orthognathic 
surgery patients about presurgical concerns, preparation for the surgical 
experience, and postsurgical outcomes. 
Nine of the 90 respondents indicated they would not re-elect the surgical 
treatment. Reasons for dissatisfaction varied, although all had in common the 
occurrence of unanticipated postsurgical events. The importance of effective 
preoperative preparation of patients cannot be overestimated. The authors have 
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written an information brochure to reinforce verbal orientation for the 
orthognathic surgery patient and family. 
Claude A. Trtpanier et al (1993)12 . Aspiration of gastric contents with 
an orogastric tube does not decrease postoperative nausea and vomiting in 
outpatients. Patients who receive this treatment had  higher incidence of 
nausea and vomiting after their discharge from the day surgery unit. 
Carrol et al (1995)8 reported a prevalence of over 30% of postdischarge  
nausea and vomiting for up to 5 days after surgery.  
David S. Precious et al (1997)14 compared the effectiveness of patient-
controlled intravenous (IV) opioid analgesic administration (PCA) with fixed 
schedule and dosage oral/rectal administration of naproxen, and opioid 
analgesics intramuscularly/orally as needed (IM/PO Prn) for postoperative 
analgesia over a period of 48 to 56 hours after surgery. There were 75 
orthognathic patients aged 25.73+_8.01 years. Subdivided into three study 
groups of 25: codeine group; naproxen group and PCA group. The degree of 
analgesia was assessed every 4 hours from 8:00AM to 8:00 PM on days 1 and 
2 post surgery using a visual analog scale. The PCA group used less than half 
the amount of morphine equivalent as the codeine group. Both the naproxen 
and the PCA groups were significantly more comfortable than the codeine 
group during day 1 and day 2 post surgery.  
The codeine group had significantly more episodes of nausea than either 
the naproxen or the PCA groups. He finally concluded that   patients 
12 
 
undergoing orthognathic surgery, naproxen and PCA regimens provided better 
analgesia than the codeine regimen. 
Girish P. Joshi et al (1999)20 suggested that the incidence of 
postoperative nausea and vomiting and the need for antiemetics do not 
increase with the use of neostigmine and glycopyrrolate  for reversal of 
residual muscle paralysis. 
Laara et al, (1999)34 it appears that this risk score has broad applicability 
in predicting PONV in adult patients undergoing inhalational anesthesia for 
various types of surgery. For patients with at least two out of these four 
identified predictors a prophylactic antiemetic strategy should be considered. 
Sinclair et al (1999)47 A validated mathematical model is provided to 
calculate the risk of PONV in outpatients having surgery. Knowing the factors 
that predict PONV will help anesthesiologists determine which patients will 
need antiemetic therapy. 
Paul F. White, et al (1999)40 if patients experience breakthrough PONV 
despite prophylaxis, they should be  treated with a drug from a group other 
than the one used for prophylaxis (e.g., metoclopramide). 
Craig Wagley et al ,(1999)13 conducted an investigation to evaluate the 
efficacy of ondansetron in controlling postoperative nausea and vomiting 
(PONV) when used prophylactically in patients undergoing routine 
dentoalveolar surgery performed under general anesthesia. 
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This was a prospective, double-blind, randomized, placebo-controlled 
evaluation. Fifty adult ASA I or II patients, requiring routine dentoalveolar 
surgery performed under general anesthesia, without a prior history of PONV, 
were randomly assigned to the experimental or control groups. Ondansetron 
(2.0 mL = 4.0 mg) or normal saline (2.0 mL) were administered intravenously 
before surgery. Age, gender, type of surgery, duration of surgery, anesthetic 
dosages, and PONV were evaluated. PONV was evaluated at time 0 (end of 
anesthesia) and at 30 and 60 minutes postoperatively. 
Nausea was evaluated using a visual analog scale (1, not nauseous; 5, 
about to vomit). Vomiting was assessed as a yes or no response. At 20 to 28 
hours postoperatively,  
No significant differences (P < .05) were found between the PONV groups 
for gender, duration of procedure, or anesthetic dosages. No statistically 
significant differences (P < .05) were noted between groups for nausea or 
vomiting. 
He finally concluded that, there were no significant differences between 
ondansetron and placebo for prophylaxis against PONVof nonresponders  and 
intractable PONV. 
Robert M. Dolman et al (2000)42, conducted a prospective study to 
compare the quality of the surgical field, blood  loss, and operative time with 
either hypotensive or normotensive anesthesia during Le Fort I osteotomies. 
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Twenty-three patients were randomized into normotensive or hypotensive 
anesthesia treatment groups. The quality of the surgical field was assessed 
intraoperatively by direct observation and again postoperatively using video 
imaging. A standardized rating scale was applied at specific intervals by 
surgeons blinded to the anesthetic technique. The surgical time was measured 
on the videotape, and blood loss was measured by volumetric and gravimetric 
techniques. There was a statistically significant correlation (P < .0001) 
between the surgeon’s perception of the quality of the surgical field and the 
blood pressure. There was also a statistically significant reduction (P < .01) in 
blood loss when using hypotensive anesthesia. However, there was no 
statistically  significant reduction  in operative time when using hypotensive 
anesthesia. It was concluded that hypotensive anesthesia is valuable in 
reducing blood loss and improving the quality of the surgical field during Le 
Fort I osteotomies, allowing for easier, more deliberate, and careful dissection. 
However, it does not reduce operative time. 
Jacqueline E. Jones et al (2001)26 gastric aspiration does not decrease the 
incidence of vomiting  following  tonsillectomy. 
Yi Lee et al ,(2001)54 Desflurane is associated with a higher incidence of 
24-h postoperative nausea and vomiting (PONV) as compared with 
sevoflurane or isoflurane. Dexamethasone 5 mg i.v. is suggested to be the 
minimum effective dose for prophylaxis of PONV in women undergoing 
thyroidectomy with isoflurane anesthesia. The objective of this study was to 
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investigate whether a 5 mg dose of dexamethasone could be enough for, or a 
larger dose at 8 mg, could be more capable of preventing PONV in women 
undergoing desflurane anesthesia for thyroidectomy. The results of this Study 
showed that in PONV prophylaxis, in female patients undergoing  desflurane  
anesthesia for thyroidectomy, the effect of dexamethasone  8 mg was superior 
to that of  dexamethasone 5 mg. 
Sebastien et al(2002)46 The latest published  score considers four risk 
factors: female gender, previous history of  PONV or motion sickness, non-
smoking status and postoperative  use of opioids (Apfel-score). The previously 
published score includes, in addition to these factors, duration, type of 
anesthesia and surgery (Sinclair-score). The two scores were compared by and 
incidence of PONV was predicted. simplified Apfel-score presented with 
favourable discriminating and calibration properties for predicting the risk of 
PONV. Therefore implementation of   this score in our daily clinical practice 
as well as in an ongoing antiemetic trial is of great importance. 
Tong J. Gan et al (2003)49  Not all surgical patients will benefit from 
antiemetic prophylaxis; thus identification of patients who are at increased risk 
leads to the most effective use of therapy and the greatest cost-efficacy. 
Although antiemetic prophylaxis cannot eliminate the risk for PONV, it can 
significantly reduce the incidence. When developing a management strategy 
for each individual patient, the choice should be based on patient preference,  
level of PONV risk. 
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Among the interventions considered, a reduction in baseline risk factors 
and use of nonpharmacologic  therapy are least likely to cause adverse events. 
PONV prophylaxis should be considered for patients at moderate to high risk 
for PONV. Depending upon the level of risk, prophylaxis should be initiated 
with monotherapy or combination therapy. Antiemetic combinations are 
recommended for patients at high risk for PONV. All prophylaxis in children 
at moderate or high risk for POV should include combination therapy using a 
5-HT3 antagonist and a second drug.  If PONV occurs within 6 h 
postoperatively, patients should not receive repeat dose of the prophylactic 
antiemetic. An emetic episode more than 6h postoperatively can be treated 
with any of the drugs used for prophylaxis except dexamethasone and 
transdermal  scopolamine. 
Nina Deutsch et al (2003)38   improvements in surgical and anesthesia 
techniques and safety over the past several years, there has been a movement 
toward performing a larger number  and different types of surgeries in the 
outpatient setting.  
L. H. J. Eberhart et al (2004)17 He conducted this survey  to evaluate the 
applicability of risk scores developed and tested in adult patients in 983 
paediatric patients (0–12 yr) undergoing various surgical procedures. He 
concluded that specialized scores for children are required. These might use 
the history of PV, strabismus surgery, duration of anaesthesia >45 min, age >5 
yr and administration of postoperative  opioids as independent risk factors. 
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Christian C. Apfel et al (2004)11 Because antiemetic interventions are 
similarly effective and act independently, the safest or least expensive should 
be used first. Prophylaxis is rarely warranted in low-risk patients, moderate-
risk patients may benefit from a single intervention, and  multiple 
interventions should be reserved for high-risk patients. 
Norbert Roewer et al (2004)39 Several risk scores were developed to 
predict PONV. For adult inpatients undergoing balanced anesthesia, a 
simplified risk score based on the number of the four risk factors (female 
gender, history of PONV or motion sickness, nonsmoking status, and expected 
need for postoperative opioids) seem to provide a valid risk assessment. When 
0, 1, 2, 3, or 4 of the four factors are present, the patient’s risk for PONV is 
about 10, 20, 40, 60, or 80%, respectively. 
Duck Hwan Choi et al (2005)15 selected five major risk factors (p≤0.000) 
to develop a predictive model. With this risk model, we can readily predict the 
probability of PONV of individual patient. As an example, if a non-smoking 
female patient who has a history of motion sickness undergoes a subtotal 
gastrectomy for 3 hr and receives PCA -based opioid, her probability of 
PONV would be 65%.we identified the major predictive risk factors for 
PONV through this large-scaled study in a Korean population and developed a 
Korean predictive model for PONV. 
In addition, this model can be used to calculate the probability of PONV in 
order to administer prophylactic antiemetics  in selected high-risk patients. 
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Samia N. Khalil et al (2005)45 ondansetron was effective when 
administered to pediatric patients before the start of surgery. Compared with 
placebo, ondansetron given before surgery resulted in significantly fewer 
patients exhibiting emesis and delayed onset of emesis in those who did 
exhibit emesis.  
Anthony L. Kovac et al (2005)2 believes that in moderate, high-, and very 
high-risk patients, the benefits prophylaxis for PONV, PDNV, and OINV 
outweigh the risks, side effects, and cost of antiemetic medications and are 
preferable to giving no prophylaxis. 
Alessandro C. Silva et al (2006)1 Suggested that Postoperative nausea 
and vomiting (PONV) is the most common postoperative complication after 
surgery and general anesthesia. PONV occurs primarily within the first 24 
hours and can lead to significant morbidity, delayed hospital discharge, 
increased hospital costs and perhaps most importantly, poor patient 
satisfaction.  
40.08% experienced PONV during the first 24 hours after surgery. The 
most important predictive factors associated with an increased risk of PONV 
were female gender, young patients (15 to 25 years old), nonsmoking status, 
presence of predisposing factors (i.e., prior history of motion sickness and/or 
PONV, vertigo or migraine headaches), use of volatile general anesthetics, 
maxillary surgery, postoperative pain level and the use of postoperative 
analgesic opioid drugs. He found a directly proportional relationship between 
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the number of risk factors and the prevalence of PONV. He concluded in his 
study that there was a high prevalence of PONV among patients undergoing 
orthognathic surgery. 
Jan Wallenborn et al (2006)28 This large randomised trial showed that the 
addition of 25mg or 50mg metoclopramide to dexamethasone (given 
intraoperatively) reduces postoperative nausea and vomiting. 
Tong J. Gan et al (2007)50 Not all surgical patients will benefit from 
antiemetic prophylaxis; thus, identification patients who are at increased risk 
is imperative. first step in reducing PONV risk is to reduce baseline risk 
factors among patients at risk. 
Drugs for PONV prophylaxis for adults should be considered for use as 
monotherapy or in combination for patients at moderate risk for PONV.  
There is increasing evidence that the combination of several potentially 
beneficial factors (multimodal approach) may lead to an improved outcome. 
Tatsuya Ichinohe et al (2007)48 evaluated  the effect of supplemental 
nitrous oxide on postoperative nausea and vomiting (PONV) after propofol 
anesthesia for orthognathic surgery in female and nonsmoking patients. 
By comparing  PONV in 28 ASA-I female nonsmoking patients 
undergoing orthognathic surgery. Anesthesia was induced with propofol 
combined with fentanyl, and tracheal intubation was facilitated with 
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vecuronium. Anesthesia was maintained with propofol with or without  nitrous 
oxide. No patient received neostigmine. PONV was assessed as score 0 (no 
PONV), score 1 (nausea), and score 2 (vomiting) during the 24-hour recovery 
period. 
There was also no difference in PONV score in 2 groups. Only 1 patient in 
each group vomited. He concluded that supplemental nitrous oxide does not 
aggravate PONV after propofol anesthesia for orthognathic surgery in female 
nonsmoking patients. 
Ethan Oliver Bryson et al (2007)18 Prophylaxis for PONV is neither cost-
effective nor indicated for low risk patients, and most medium risk patients 
can be effectively treated with a single agent. When administering an 
anesthetic to a patient at high risk for developing PONV, the plan should 
include pre-medication to reduce anxiety, agents that reduce the need for 
intraoperative and postoperative opioids, and the use of regional anesthetic 
techniques whenever possible. If general anesthesia cannot be avoided, agents 
such as propofol for induction and maintenance of anesthesia should be used 
to avoid or reduce the need for nitrous oxide and the potent inhaled agents. 
A combination of antiemetic prophylactic agents should be administered to 
those judged to be at high risk for developing PONV, and adequate 
intravenous therapy should avoid dehydration and hypotension 
postoperatively. 
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Michael J et al (2007)36   All combinations were associated with a low 
incidence of nausea vomiting. dexamethasone 2 mg plus ondansetron 2 mg not 
significantly different to other dose combinations except that, groups receiving 
2 mg dexamethasone  alone  had a more frequent incidence of nausea. 
Werner Joseph et al  (2008)53 The exact mechanism of smoking reducing 
the incidence of PONV is not fully explained; however, there are several 
potential explanations. Chronic exposure to one of the chemicals in tobacco 
may desensitize the patient to anesthetic gas or may a have direct antiemetic 
effect. Another explanation is that the cytochrome p450 may be up-regulated 
in chronic smokers, which may increase metabolism of anesthetic agents and 
result in less PONV. 
F. Yoshikawa et al (2009)19 Hypotensive anaesthesia using sodium 
nitroprusside or nitroglyerine reduced blood loss and the duration of 
mandibular  osteotomy.The hormonal responses, indicated by plasma levels of 
ACTH, cortisol and dopamine, were activated by SNP, NTG and sevoflurane 
in the control group. No significant difference in these hormonal responses 
was observed  between the 3 groups. SNP and NTG can be used safely for 
hypotensive anaesthesia during mandibular osteotomy if mean arterial 
pressure is maintained between 60 and 70 mmHg. 
Waleed Riad et al (2009)51 Pediatric strabismus surgery is commonly 
associated with higher incidence of postoperative nausea and vomiting 
(PONV). Mixtures of different classes of antiemetics have been used 
successfully to decrease the incidence of PONV but there was no agreement 
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on the optimal combination. The aim of this study was to investigate the effect 
of granisetron, ondansetron, midazolam combination with dexamethasone in 
the prevention of PONV following strabismus repair in pediatric population. 
 He concluded from the study that Prophylactic administration of either of 
either granisetron, ondansetron, midazolam combined with dexamethasone 
markedly decreases the incidence of PONV following strabismus surgery in 
pediatrics. All combinations are equally effective. 
Ju Ahmed et al (2009)31  A non -randomized case control study of 
prevention of post operative nausea and vomiting  with IV- Granisetron was 
done on 270 adult surgical patients who received general or spinal anesthesia. 
All the patients were followed up to 48 hours after operation. A complete 
response was achieved in prophylaxis group   as 92.6% and in control group as 
90.4% (p-value=0.6637).Majority of patients (90 to 100 %) had PONV within   
24 hours after operation. As there is insignificant difference in the 
achievement between prophylaxis group and control group, anti emetic 
prophylaxis is recommended  only for patient with one or more risk factors for 
PONV. 
Mohan Alexander et al (2009)37 concluded that there does not appear to 
be a rationale for the prophylactic administration of antiemetic drugs in such 
surgical procedures. A watch-and-wait policy and simple GL may provide 
significant relief. Antiemetic medications are to be considered only in case.  
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REVIEW OF LITERATURE 
J.W. Dundee et al  (1975)16 The ability of cyclizine (50 mg) and 
perphenazine (2.5 and 5.0 mg) to counteract the emetic effects of pethidine 
(100 mg) and morphine (10 and 15 mg) was compared in women undergoing a 
standard minor operation with a standard anaesthetic.  Perphenazine (5.0 mg) 
was as effective an anti-emetic as cyclizine (50 mg) and both were more 
effective than perphenazine (2.5 mg). The reduction in vomiting and nausea 
by cycizine (50 mg) and perphenazine (5 mg) was approximately the same 
following pethidine (100 mg) and morphine (10 mg) but much less against the 
larger dose of morphine. Both anti-emetics had a rapid onset of action but their 
anti-emetic activity did not last as long as the emetic effect of morphine. 
Perphenazine (5 mg) was accompanied by an unacceptably high incidence of 
restlessness. In clinical practice cyclizine (50 mg) is preferred to perphenazine 
(5 mg) as an antiemetic. 
Carolyn M. Flanary et al (1983)7  The authors surveyed 93 orthognathic 
surgery patients about presurgical concerns, preparation for the surgical 
experience, and postsurgical outcomes. 
Nine of the 90 respondents indicated they would not re-elect the surgical 
treatment. Reasons for dissatisfaction varied, although all had in common the 
occurrence of unanticipated postsurgical events. The importance of effective 
preoperative preparation of patients cannot be overestimated. The authors have 
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written an information brochure to reinforce verbal orientation for the 
orthognathic surgery patient and family. 
Claude A. Trtpanier et al (1993)12 . Aspiration of gastric contents with 
an orogastric tube does not decrease postoperative nausea and vomiting in 
outpatients. Patients who receive this treatment had  higher incidence of 
nausea and vomiting after their discharge from the day surgery unit. 
Carrol et al (1995)8 reported a prevalence of over 30% of postdischarge
nausea and vomiting for up to 5 days after surgery.  
David S. Precious et al (1997)14 compared the effectiveness of patient-
controlled intravenous (IV) opioid analgesic administration (PCA) with fixed 
schedule and dosage oral/rectal administration of naproxen, and opioid 
analgesics intramuscularly/orally as needed (IM/PO Prn) for postoperative 
analgesia over a period of 48 to 56 hours after surgery. There were 75 
orthognathic patients aged 25.73+_8.01 years. Subdivided into three study 
groups of 25: codeine group; naproxen group and PCA group. The degree of 
analgesia was assessed every 4 hours from 8:00AM to 8:00 PM on days 1 and 
2 post surgery using a visual analog scale. The PCA group used less than half 
the amount of morphine equivalent as the codeine group. Both the naproxen 
and the PCA groups were significantly more comfortable than the codeine 
group during day 1 and day 2 post surgery.  
The codeine group had significantly more episodes of nausea than either 
the naproxen or the PCA groups. He finally concluded that   patients 
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undergoing orthognathic surgery, naproxen and PCA regimens provided better 
analgesia than the codeine regimen. 
Girish P. Joshi et al (1999)20 suggested that the incidence of 
postoperative nausea and vomiting and the need for antiemetics do not 
increase with the use of neostigmine and glycopyrrolate  for reversal of 
residual muscle paralysis. 
Laara et al, (1999)34 it appears that this risk score has broad applicability 
in predicting PONV in adult patients undergoing inhalational anesthesia for 
various types of surgery. For patients with at least two out of these four 
identified predictors a prophylactic antiemetic strategy should be considered.
Sinclair et al (1999)47 A validated mathematical model is provided to 
calculate the risk of PONV in outpatients having surgery. Knowing the factors 
that predict PONV will help anesthesiologists determine which patients will 
need antiemetic therapy.
Paul F. White, et al (1999)40 if patients experience breakthrough PONV 
despite prophylaxis, they should be  treated with a drug from a group other 
than the one used for prophylaxis (e.g., metoclopramide). 
Craig Wagley et al ,(1999)13 conducted an investigation to evaluate the 
efficacy of ondansetron in controlling postoperative nausea and vomiting 
(PONV) when used prophylactically in patients undergoing routine 
dentoalveolar surgery performed under general anesthesia. 
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This was a prospective, double-blind, randomized, placebo-controlled 
evaluation. Fifty adult ASA I or II patients, requiring routine dentoalveolar 
surgery performed under general anesthesia, without a prior history of PONV, 
were randomly assigned to the experimental or control groups. Ondansetron 
(2.0 mL = 4.0 mg) or normal saline (2.0 mL) were administered intravenously 
before surgery. Age, gender, type of surgery, duration of surgery, anesthetic 
dosages, and PONV were evaluated. PONV was evaluated at time 0 (end of 
anesthesia) and at 30 and 60 minutes postoperatively. 
Nausea was evaluated using a visual analog scale (1, not nauseous; 5, 
about to vomit). Vomiting was assessed as a yes or no response. At 20 to 28 
hours postoperatively,  
No significant differences (P < .05) were found between the PONV groups 
for gender, duration of procedure, or anesthetic dosages. No statistically 
significant differences (P < .05) were noted between groups for nausea or 
vomiting. 
He finally concluded that, there were no significant differences between 
ondansetron and placebo for prophylaxis against PONVof nonresponders  and 
intractable PONV. 
Robert M. Dolman et al (2000)42, conducted a prospective study to 
compare the quality of the surgical field, blood  loss, and operative time with 
either hypotensive or normotensive anesthesia during Le Fort I osteotomies.
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Twenty-three patients were randomized into normotensive or hypotensive 
anesthesia treatment groups. The quality of the surgical field was assessed 
intraoperatively by direct observation and again postoperatively using video 
imaging. A standardized rating scale was applied at specific intervals by 
surgeons blinded to the anesthetic technique. The surgical time was measured 
on the videotape, and blood loss was measured by volumetric and gravimetric 
techniques. There was a statistically significant correlation (P < .0001) 
between the surgeon’s perception of the quality of the surgical field and the 
blood pressure. There was also a statistically significant reduction (P < .01) in 
blood loss when using hypotensive anesthesia. However, there was no 
statistically  significant reduction  in operative time when using hypotensive 
anesthesia. It was concluded that hypotensive anesthesia is valuable in 
reducing blood loss and improving the quality of the surgical field during Le 
Fort I osteotomies, allowing for easier, more deliberate, and careful dissection. 
However, it does not reduce operative time. 
Jacqueline E. Jones et al (2001)26 gastric aspiration does not decrease the 
incidence of vomiting  following  tonsillectomy. 
Yi Lee et al ,(2001)54 Desflurane is associated with a higher incidence of 
24-h postoperative nausea and vomiting (PONV) as compared with 
sevoflurane or isoflurane. Dexamethasone 5 mg i.v. is suggested to be the 
minimum effective dose for prophylaxis of PONV in women undergoing 
thyroidectomy with isoflurane anesthesia. The objective of this study was to 
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investigate whether a 5 mg dose of dexamethasone could be enough for, or a 
larger dose at 8 mg, could be more capable of preventing PONV in women 
undergoing desflurane anesthesia for thyroidectomy. The results of this Study 
showed that in PONV prophylaxis, in female patients undergoing  desflurane  
anesthesia for thyroidectomy, the effect of dexamethasone  8 mg was superior 
to that of  dexamethasone 5 mg. 
Sebastien et al(2002)46 The latest published  score considers four risk 
factors: female gender, previous history of  PONV or motion sickness, non-
smoking status and postoperative  use of opioids (Apfel-score). The previously 
published score includes, in addition to these factors, duration, type of 
anesthesia and surgery (Sinclair-score). The two scores were compared by and 
incidence of PONV was predicted. simplified Apfel-score presented with 
favourable discriminating and calibration properties for predicting the risk of 
PONV. Therefore implementation of   this score in our daily clinical practice 
as well as in an ongoing antiemetic trial is of great importance. 
Tong J. Gan et al (2003)49  Not all surgical patients will benefit from 
antiemetic prophylaxis; thus identification of patients who are at increased risk 
leads to the most effective use of therapy and the greatest cost-efficacy. 
Although antiemetic prophylaxis cannot eliminate the risk for PONV, it can 
significantly reduce the incidence. When developing a management strategy 
for each individual patient, the choice should be based on patient preference,  
level of PONV risk. 
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Among the interventions considered, a reduction in baseline risk factors 
and use of nonpharmacologic  therapy are least likely to cause adverse events. 
PONV prophylaxis should be considered for patients at moderate to high risk 
for PONV. Depending upon the level of risk, prophylaxis should be initiated 
with monotherapy or combination therapy. Antiemetic combinations are 
recommended for patients at high risk for PONV. All prophylaxis in children 
at moderate or high risk for POV should include combination therapy using a 
5-HT3 antagonist and a second drug.  If PONV occurs within 6 h 
postoperatively, patients should not receive repeat dose of the prophylactic 
antiemetic. An emetic episode more than 6h postoperatively can be treated 
with any of the drugs used for prophylaxis except dexamethasone and 
transdermal  scopolamine. 
Nina Deutsch et al (2003)38  improvements in surgical and anesthesia 
techniques and safety over the past several years, there has been a movement 
toward performing a larger number  and different types of surgeries in the 
outpatient setting.  
L. H. J. Eberhart et al (2004)17 He conducted this survey  to evaluate the 
applicability of risk scores developed and tested in adult patients in 983 
paediatric patients (0–12 yr) undergoing various surgical procedures. He 
concluded that specialized scores for children are required. These might use 
the history of PV, strabismus surgery, duration of anaesthesia >45 min, age >5 
yr and administration of postoperative  opioids as independent risk factors. 
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Christian C. Apfel et al (2004)11 Because antiemetic interventions are 
similarly effective and act independently, the safest or least expensive should 
be used first. Prophylaxis is rarely warranted in low-risk patients, moderate-
risk patients may benefit from a single intervention, and  multiple 
interventions should be reserved for high-risk patients. 
Norbert Roewer et al (2004)39 Several risk scores were developed to 
predict PONV. For adult inpatients undergoing balanced anesthesia, a 
simplified risk score based on the number of the four risk factors (female 
gender, history of PONV or motion sickness, nonsmoking status, and expected 
need for postoperative opioids) seem to provide a valid risk assessment. When 
0, 1, 2, 3, or 4 of the four factors are present, the patient’s risk for PONV is 
about 10, 20, 40, 60, or 80%, respectively. 
Duck Hwan Choi et al (2005)15 selected five major risk factors (p0.000)
to develop a predictive model. With this risk model, we can readily predict the 
probability of PONV of individual patient. As an example, if a non-smoking 
female patient who has a history of motion sickness undergoes a subtotal 
gastrectomy for 3 hr and receives PCA -based opioid, her probability of 
PONV would be 65%.we identified the major predictive risk factors for 
PONV through this large-scaled study in a Korean population and developed a 
Korean predictive model for PONV. 
In addition, this model can be used to calculate the probability of PONV in 
order to administer prophylactic antiemetics  in selected high-risk patients. 
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Samia N. Khalil et al (2005)45 ondansetron was effective when 
administered to pediatric patients before the start of surgery. Compared with 
placebo, ondansetron given before surgery resulted in significantly fewer 
patients exhibiting emesis and delayed onset of emesis in those who did 
exhibit emesis.  
Anthony L. Kovac et al (2005)2 believes that in moderate, high-, and very 
high-risk patients, the benefits prophylaxis for PONV, PDNV, and OINV 
outweigh the risks, side effects, and cost of antiemetic medications and are 
preferable to giving no prophylaxis. 
Alessandro C. Silva et al (2006)1 Suggested that Postoperative nausea 
and vomiting (PONV) is the most common postoperative complication after 
surgery and general anesthesia. PONV occurs primarily within the first 24 
hours and can lead to significant morbidity, delayed hospital discharge, 
increased hospital costs and perhaps most importantly, poor patient 
satisfaction.  
40.08% experienced PONV during the first 24 hours after surgery. The 
most important predictive factors associated with an increased risk of PONV 
were female gender, young patients (15 to 25 years old), nonsmoking status, 
presence of predisposing factors (i.e., prior history of motion sickness and/or 
PONV, vertigo or migraine headaches), use of volatile general anesthetics, 
maxillary surgery, postoperative pain level and the use of postoperative 
analgesic opioid drugs. He found a directly proportional relationship between 
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the number of risk factors and the prevalence of PONV. He concluded in his 
study that there was a high prevalence of PONV among patients undergoing 
orthognathic surgery. 
Jan Wallenborn et al (2006)28 This large randomised trial showed that the 
addition of 25mg or 50mg metoclopramide to dexamethasone (given 
intraoperatively) reduces postoperative nausea and vomiting. 
Tong J. Gan et al (2007)50 Not all surgical patients will benefit from 
antiemetic prophylaxis; thus, identification patients who are at increased risk 
is imperative. first step in reducing PONV risk is to reduce baseline risk 
factors among patients at risk. 
Drugs for PONV prophylaxis for adults should be considered for use as 
monotherapy or in combination for patients at moderate risk for PONV.  
There is increasing evidence that the combination of several potentially 
beneficial factors (multimodal approach) may lead to an improved outcome. 
Tatsuya Ichinohe et al (2007)48 evaluated  the effect of supplemental 
nitrous oxide on postoperative nausea and vomiting (PONV) after propofol 
anesthesia for orthognathic surgery in female and nonsmoking patients. 
By comparing  PONV in 28 ASA-I female nonsmoking patients 
undergoing orthognathic surgery. Anesthesia was induced with propofol 
combined with fentanyl, and tracheal intubation was facilitated with 
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vecuronium. Anesthesia was maintained with propofol with or without  nitrous 
oxide. No patient received neostigmine. PONV was assessed as score 0 (no 
PONV), score 1 (nausea), and score 2 (vomiting) during the 24-hour recovery 
period. 
There was also no difference in PONV score in 2 groups. Only 1 patient in 
each group vomited. He concluded that supplemental nitrous oxide does not 
aggravate PONV after propofol anesthesia for orthognathic surgery in female 
nonsmoking patients. 
Ethan Oliver Bryson et al (2007)18 Prophylaxis for PONV is neither cost-
effective nor indicated for low risk patients, and most medium risk patients 
can be effectively treated with a single agent. When administering an 
anesthetic to a patient at high risk for developing PONV, the plan should 
include pre-medication to reduce anxiety, agents that reduce the need for 
intraoperative and postoperative opioids, and the use of regional anesthetic 
techniques whenever possible. If general anesthesia cannot be avoided, agents 
such as propofol for induction and maintenance of anesthesia should be used 
to avoid or reduce the need for nitrous oxide and the potent inhaled agents. 
A combination of antiemetic prophylactic agents should be administered to 
those judged to be at high risk for developing PONV, and adequate 
intravenous therapy should avoid dehydration and hypotension 
postoperatively. 
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Michael J et al (2007)36   All combinations were associated with a low 
incidence of nausea vomiting. dexamethasone 2 mg plus ondansetron 2 mg not 
significantly different to other dose combinations except that, groups receiving 
2 mg dexamethasone  alone  had a more frequent incidence of nausea. 
Werner Joseph et al  (2008)53 The exact mechanism of smoking reducing 
the incidence of PONV is not fully explained; however, there are several 
potential explanations. Chronic exposure to one of the chemicals in tobacco 
may desensitize the patient to anesthetic gas or may a have direct antiemetic 
effect. Another explanation is that the cytochrome p450 may be up-regulated 
in chronic smokers, which may increase metabolism of anesthetic agents and 
result in less PONV. 
F. Yoshikawa et al (2009)19 Hypotensive anaesthesia using sodium 
nitroprusside or nitroglyerine reduced blood loss and the duration of 
mandibular  osteotomy.The hormonal responses, indicated by plasma levels of 
ACTH, cortisol and dopamine, were activated by SNP, NTG and sevoflurane 
in the control group. No significant difference in these hormonal responses 
was observed  between the 3 groups. SNP and NTG can be used safely for 
hypotensive anaesthesia during mandibular osteotomy if mean arterial 
pressure is maintained between 60 and 70 mmHg. 
Waleed Riad et al (2009)51 Pediatric strabismus surgery is commonly 
associated with higher incidence of postoperative nausea and vomiting 
(PONV). Mixtures of different classes of antiemetics have been used 
successfully to decrease the incidence of PONV but there was no agreement 
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on the optimal combination. The aim of this study was to investigate the effect 
of granisetron, ondansetron, midazolam combination with dexamethasone in 
the prevention of PONV following strabismus repair in pediatric population. 
 He concluded from the study that Prophylactic administration of either of 
either granisetron, ondansetron, midazolam combined with dexamethasone 
markedly decreases the incidence of PONV following strabismus surgery in 
pediatrics. All combinations are equally effective.
Ju Ahmed et al (2009)31  A non -randomized case control study of 
prevention of post operative nausea and vomiting  with IV- Granisetron was 
done on 270 adult surgical patients who received general or spinal anesthesia. 
All the patients were followed up to 48 hours after operation. A complete 
response was achieved in prophylaxis group   as 92.6% and in control group as 
90.4% (p-value=0.6637).Majority of patients (90 to 100 %) had PONV within   
24 hours after operation. As there is insignificant difference in the 
achievement between prophylaxis group and control group, anti emetic 
prophylaxis is recommended  only for patient with one or more risk factors for 
PONV. 
Mohan Alexander et al (2009)37 concluded that there does not appear to 
be a rationale for the prophylactic administration of antiemetic drugs in such 
surgical procedures. A watch-and-wait policy and simple GL may provide 
significant relief. Antiemetic medications are to be considered only in case. 
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RESULTS 
 
A total of  25 patients were analyzed in this survey. 
Of the 25 patients included in the study 5 patients (20%) experienced PONV. 
Gender & Age  
Our population consisted of 40% male (10/25) & 60% females (15/25) with a  
female to male ratio of 3:2. 
Among 5 patients who developed PONV 40% (2/5) were male and 60% (3/5) 
were females. 
The relationship between PONV and female gender was not statistically 
significant based on the p value criteria 
The age of the patients  enrolled in this study ranged  from 15-50 years with a 
mean of 32.5  
Patients aged between 15-25 yrs showed greatest incidence of PONV (60%), 
with a noteworthy statistically significant reduction of  emetic events with 
increasing of age.  
Age & PONV were statistically related  (P = 0.041 ) 
There was decrease in incidence of PONV as age increased and a higher 
incidence of PONV in females in all age groups compared with males. 
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Table 1 : Frequency of PONV in different age groups 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Below 20 6 24.0 24.0 24.0
  21-25 14 56.0 56.0 80.0
  Above 25 5 20.0 20.0 100.0
  Total 25 100.0 100.0  
 
Table 2 : Percentage of PONV Vs. Age  
Age Group in years 
  PONV Total 
  1 2 3 4   
 Below 20 Count 2 0 1 3 6
    % within 
Age Group 
in years 
33.3% .0% 16.7% 50.0% 100.0%
    % within 
PONV 11.8% .0% 100.0% 60.0% 24.0%
  21-25 Count 12 0 0 2 14
    % within 
Age Group 
in years 
85.7% .0% .0% 14.3% 100.0%
    % within 
PONV 70.6% .0% .0% 40.0% 56.0%
  Above 25 Count 3 2 0 0 5
    % within 
Age Group 
in years 
60.0% 40.0% .0% .0% 100.0%
    % within 
PONV 17.6% 100.0% .0% .0% 20.0%
Total Count 17 2 1 5 25
  % within 
Age Group 
in years 
68.0% 8.0% 4.0% 20.0% 100.0%
  % within 
PONV 100.0% 100.0% 100.0% 100.0% 100.0%
   
  Pearson Chi-Square test and Co-relation test were performed 
P = 0.041 (significant) 
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Table  3 : Frequency of PONV in Male and Female Gender 
 
Table 4 :  Percentage of PONV Vs. Gender 
Gender 
  
  PONV Total 
  1 2 3 4   
 Male Count 7 1 0 2 10
    % within 
Gender 70.0% 10.0% .0% 20.0% 100.0%
    % within 
PONV 41.2% 50.0% .0% 40.0% 40.0%
  Female Count 10 1 1 3 15
    % within 
Gender 66.7% 6.7% 6.7% 20.0% 100.0%
    % within 
PONV 58.8% 50.0% 100.0% 60.0% 60.0%
Total Count 17 2 1 5 25
  % within 
Gender 68.0% 8.0% 4.0% 20.0% 100.0%
  % within 
PONV 100.0% 100.0% 100.0% 100.0% 100.0%
 
Pearson Chi-Square test and Co-relation test were performed 
P value = 0.76 ( not statistically significant)
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Male 10 40.0 40.0 40.0 
Female 15 60.0 60.0 100.0 
Total 25 100.0 100.0   
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Co-morbidities, ASA Status  
None of the patients had any co-morbidities. Only 2/25 patients were ASA II 
(81% ). Of the two patients, 1 patient (50%) experienced PONV. 
The result showed no statistical relationship between co-morbidity and 
incidence of PONV (P = 0.062) 
- Patients were  classified  as ASA I 23 (92%) and ASA II (8%) 2 
patients. 
- X2 test relating ASA (classification) to PONV did not show a  
statistical relationship (P= 0.062 ) 
Table 5 :  Frequency of PONV in ASA I & ASA II 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid I 23 92.0 92.0 92.0 
II 2 8.0 8.0 100.0 
Total 25 100.0 100.0   
Table 6 : Percentage of PONV Vs.  ASA status 
ASA Status   PONV Total 
    1 2 3 4   
 I Count 17 1 1 4 23
    % within ASA 
Status 73.9% 4.3% 4.3% 17.4% 100.0%
    % within PONV 100.0% 50.0% 100.0% 80.0% 92.0%
  II Count 0 1 0 1 2
    % within ASA 
Status .0% 50.0% .0% 50.0% 100.0%
    % within PONV .0% 50.0% .0% 20.0% 8.0%
Total Count 17 2 1 5 25
  % within ASA 68.0% 8.0% 4.0% 20.0% 100.0%
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Status 
  % within  100.0% 100.0% 100.0% 100.0% 100.0%
Smoking status  
All patients included in this study were non-smokers 25/25 (100%).  
Incidence of PONV is higher in non smoking population . 
Predisposing factors : History of motion sickness, prior PONV, Vertigo, 
migraine and headaches. 
- Majority of  the patients medical charts did not report any predisposing 
factors. 24 patients had no predisposing factors (96%). 1 patient (4%) 
had History of  motion sickness and experienced PONV. 
- Of all the predisposing factors , a prior history of PONV was the most 
important predictive factor of PONV. 
Preanaesthetic medication: 
All patients 25/25 100% received preanaesthetic medication. 
All  patients received Fortwin (IM), Phenargan (IM) & glycopyrrolate (IM) 
No statistically significant correlation with PONV was established. 
Mensturation & Hormone therapy: 
Of 14 (56%) female patient only 1 (4%) patient had menstruation during her 
period of admission. She experienced  PONV  in the postoperative period. 
No stastistically significant correlation was established with PONV  
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Intraoperative factors & PONV 
Site of Surgery  
Most of the patients (12) 48% in this study underwent bimaxillary surgeries  
Maxillary surgeries alone in 9 patients (36%) 
Mandibular surgeries alone in 4 patients ( 16%) 
In our study incidence of PONV was higher in patients undergoing bimaxilary 
procedures. 
 
Table 7 : PONV rates according to surgical sites 
 
Duration of procedure 
There was statistically significant correlation between the procedure duration 
and PONV  (p = 0.01) 
The longer the procedure, the greater was the incidence of PONV.  
 
Surgical 
Sites 
Patients with 
PONV 
Percentage of 
PONV 
Total 
Patients 
Percentage of 
Total 
Mandible 1 25% 4 16% 
Maxilla 0 0% 9 36% 
Max/Mand 4 33.3% 12 48% 
Total 5 20% 25 100% 
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Table 8 : PONV rates and procedure duration 
Duration 
In hours 
Patients 
with PONV 
Percentage of 
PONV 
Total 
number of 
patients 
Percentage of 
total 
2.30 - 3.00 0 0% 7 28% 
3.00  -3.30 1 11.1% 9 36% 
3.30 – 4.00 2 50% 4 16% 
4.00 – 4.30 2 66.6% 3 12% 
4.30 – 5.00 0 0 2 8% 
 
Medications 
All patients received steroids (Dexamethasone 8mg intravenously) 
intraoperatively and  postoperatively for two days  12 hourly . Antibiotics  - 
Cefotaxim  (1gm/IV) was given intraoperatively  and postoperatively, 
continued for 3 days  12 hourly . In few patients  Ampicillin (500mg/IV) was 
given intraoperatively and postoperatively continued for 3 days  8 hourly .  
Metrogyl (500mg/IV) was given intraoperatively and postoperatively  for 3 
days  8 hourly . Medication was changed to oral antibiotic syrups after the 
third day and continued for 5 more days. 
Emset 4mg (IV) was given intraoperatively for all patients and continued 
postoperatively for the two days at 12 hour interval. Rantidine 50mg IV was 
given intraoperatively and postoperatively  for all patients.  
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No allergic reactions were noticed in any of the patients.  
Anaesthetic medications :  
In majority of the  patients, anaesthesia was induced using  Sodium 
Thiopentone  (IV) in 23 patients (92%), Propofol, Glycopyrrolate, Fortwin  in 
2 (8%) cases was given intravenously. 
Inhalation agents used were nitrous oxide & oxygen in 6 patients (24%) and 
Nitrous Oxide along with  Oxygen  and  0.5% intermittent  halothane in 19 
patients (76%) to maintain general anaesthesia. 
- Incidence of PONV was higher (80%) when an inhalation agent 
(Halothane 0.5% Intermittent) was used along with Nitrous Oxide and 
Oxygen compared to 20% when Nitrous Oxide and Oxygen used 
alone.  
- Approximately 4 patients  experienced PONV (80%) when Halothane 
0.5% Intermittent was used along with Nitrous Oxide and Oxygen. 
Only one patient experienced PONV (20%)   when only Nitrous Oxide 
and Oxygen was used. 
- Hypotensive anaesthesia  in the form of Nitroglycerine IV drip was 
given in all patients at the beginning of the procedure.  
- Intraoperative Opioids were not used.  
- Voveran (IM) was administered in all 25 patients and of these, 5 (20%) 
experienced PONV. Muscle relaxants like Norcurarium was used 
along with succinylcholine. Reversal drugs like Neostigmine             
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2.5 mg (IV) was used in all cases  in addition to Glycopyrrolate            
0.5mg (IV) 
- When used, the most common of these was glycopyrrolate (0.5mg IV) 
combined with neostigmine (2.5mg IV).  
-  Statistical analysis was not possible since all the patients were treated 
with the same protocol.  
 
POSTOPERATIVE FACTORS AND PONV 
There were 20 patients who did not experience PONV (80%). Among those 
patients who did experience PONV (20%, 5/25), all episodes occurred only in 
the PACU. 
Postoperative Analgesics 
Postoperative pain was treated in both the PACU and SSU, on a12 hourly  
basis, with intramuscular NSAIDS (Voveran 3ml IM). After the 2nd 
postoperative day pain was treated on “as and when basis”. 
Pain Level 
The pain level was measured using a visual analog scale and rated as mild 
moderate and severe. This was done consistently in the PACU but was found 
to be extremely variable in the SSU. As such, the relationship between pain 
level and the occurrence of PONV was only evaluated while patients were in 
the PACU . 
Increase in pain level resulted in increased incidence of PONV. 
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Table  9 :  Percentage of PONV  Vs. Pain level 
Pain level 
  
  PONV Total 
  1 2 3 4   
 Mild Count 4 1 0 0 5
    % within 
Pain level 80.0% 20.0% .0% .0% 100.0%
    % within 
PONV 23.5% 50.0% .0% .0% 20.0%
  Moderate Count 9 1 0 0 10
    % within 
Pain level 90.0% 10.0% .0% .0% 100.0%
    % within 
PONV 52.9% 50.0% .0% .0% 40.0%
  Severe Count 4 0 1 5 10
    % within 
Pain level 40.0% .0% 10.0% 50.0% 100.0%
    % within 
PONV 23.5% .0% 100.0% 100.0% 40.0%
Total Count 17 2 1 5 25
  % within 
Pain level 68.0% 8.0% 4.0% 20.0% 100.0%
  % within 
PONV 100.0% 100.0% 100.0% 100.0% 100.0%
 
Pearson Chi-Square test and Co-relation test were performed 
P < 0.05  
Antiemetics 
PONV episodes in the PACU were treated with ondansetron 4 mg (IV). 
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BSSO Sub apical osteotomy Genioplasty Lefort I
Anterior Maxilary 
Osteotomy PMO
1 Case 1 Setback  Setup 4 mm set back
2 Case 2 Advancement setup
3 Case 3 Advancement 7 mm
setup 3mm             Set 
back 5mm
4 Case 4 Setup (5m) setup(2 mm) Setback (5 mm)
5 Case 5 Advancement 5mm Setup 2mm Setback 5mm
6 Case 6 Setup
7 Case 7 Setback 4mm Setback 4mm
8 Case 8 Advancement 5 mm setup setup & setback
9 Case 9 Advancement  5m
10 Case 10 Setup setup & setback Advancement
11 Case 11 Setup 3mm             Set back 3 mm
12 Case 12 Setup 10 set back 
13 Case 13 advancement
14 Case 14 Sub apical set back 5m
setup 2m             Set back 
5m
15 Case 15 setup 
16 Case 16 Setback 8mm Advancement 4mm
17 Case 17 5mm impaction Setup 7mm             Set back 6.5 mm
18 Case 18 Advancement setup 2m             Set back 
19 Case 19 Advancement + Reduction Setup 7
20 Case 20 Advancement Setup 5mm Set back 3mm
21 Case 21 Setup
22 Case 22 Advancement 6mm 
23 Case 23 Reduction 5 + Advancement setup 5 set back
24 Case 24 Advancement 6m
Advancement - 
3m            
25 Case 25 Advancement 6m
Advancement - 
5m            
S.NO
Mandibular Procetures Maxillary Procedures
INTRA OPERATIVE
Name
1 Case 1
2 Case 2
3 Case 3
4 Case 4
5 Case 5
6 Case 6
7 Case 7
8 Case 8
9 Case 9
10 Case 10
11 Case 11
12 Case 12
13 Case 13
14 Case 14
15 Case 15
16 Case 16
17 Case 17
18 Case 18
19 Case 19
20 Case 20
21 Case 21
22 Case 22
23 Case 23
24 Case 24
25 Case 25
S.NO Name
Emset 4 mg Severe 2
Emset 4 mg Severe 3
Emset 4 mg Moderate 0
Emset 4 mg Moderate 0
Emset 4 mg Mild 0
Emset 4 mg Moderate 1
Emset 4 mg Severe 3
Emset 4 mg Severe 3
Emset 4 mg Moderate 0
Emset 4 mg Severe 0
Emset 4 mg Mild 0
Emset 4 mg Moderate 0
Emset 4 mg Severe 0
Emset 4 mg Mild 0
Emset 4 mg Mild 0
Emset 4 mg Severe 3
Emset 4 mg Moderate 0
Emset 4 mg Mild 1
Emset 4 mg Severe 0
Emset 4 mg Moderate 0
Emset 4 mg Moderate 0
Emset 4 mg Severe 0
Emset 4 mg Moderate 0
Emset 4 mg Severe 3
Emset 4 mg Moderate 0
Antimetics Pain level .
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DISCUSSION 
The results of this study showed a  incidence of 20% PONV among 
orthognathic surgery patients during their hospital stay . We verified Apfel’s 
4-factor risk score in our patient population and found that the multimodal 
prophylaxis for PONV was not particularly effective  for high risk patients.  
We found that the most important risk factors in our patient population 
were: 
1. Younger age (especially those in the 15 to 25 year old group) 
2. Patients with any reported predisposing factors for PONV 
3. Surgical procedures that lasted longer than 2 hours 
4. Bimaxillary surgeries 
5. The use of any inhalational agent 
6. Patients who reported high levels of pain in the PACU 
This study has specifically analyzed the incidence of PONV, and 
related risk factors, among orthognathic surgery patients.  Nausea and 
vomiting were considered a single event and termed as PONV. The incidence 
of PONV was  monitored in PACU( 20% ).  
There is an increasing concern that the actual incidence of PONV after 
hospital discharge may be underestimated. Carrol et al8  reported the 
prevalence of 30%  post discharge PONV for upto 5 days after surgery.  
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 Associated  orofacial swelling, and swallowing blood are common in 
the early postoperative period after orthognathic surgery, especially those 
surgeries in which the maxilla was involved. The combination of all these 
factors may be associated with a higher incidence  of PONV. 
The risk factors can be divided into nonanesthetic or preoperative 
related factors, anesthetic or intraoperative surgery  related factors and 
postoperative-related factors. 
PREOPERATIVE-RELATED FACTORS 
Many patient characteristics can influence the incidence of PONV. 
Among these are: Age, gender, previous history of PONV, motion sickness, 
vertigo or migraine headaches. In our population, we found a statistically 
significant relationship between age and  PONV. The younger the patient, the 
more likely they were to experience PONV. We observed a marked reduction 
in PONV as the patient’s age increased .Sinclair et al 47 described similar 
results, pointing out that age decreased the likelihood of  PONV by 13% for 
every 10-year increase of age. Our patient population consisted of all  
nonsmoking individuals . It is well-known that adult males are less likely  to 
experience PONV than are adult females (Watcha MF 52, White PF)  
Our results showed an approximate  20%  of high   incidence of PONV 
among females compared to  males and suggest a statistical influence of 
female  gender on the incidence of PONV.  
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One explanation may be the intense fluctuation in hormone levels 
during the menstrual cycle1,25. Women have an increased risk of PONV i.e 2 
to 3 times greater than men.1,34.Many investigators have stated that 
nonsmoking  patients are more susceptible to PONV than are smokers, 
especially when other risk factors are considered..  
Apfel and his colleagues4,34, hypothesized about the relationship of 
smoking and PONV, suggested that smoking may have an effect on the 
dopaminergic system, thereby diminishing PONV. In the same way, Chimbira 
and Sweeney 10 have suggested  the possibility that inhibition of emetic events 
by cigarettes may be due to increased hepatic enzymes, especially cytochrome 
P450. These isoenzymes are responsible for the breakdown, and early 
excretion, of ingested or inhaled chemicals and toxins, thus diminishing the 
emetic effect of such drugs. The mechanism by which smoking could 
contribute to decreased PONV is not completely understood, but the role of 
hepatic enzymes seems to be the most  reasonable explanation. We did not 
observe such a relationship. This may be due absence of smoking individuals 
in our study. 
Comparing the mean age of the patients with ASA group, Watcha et al 
and White et al 52,32 found an increase in the mean age as the ASA status 
increased.  Although the actual number of patients who self-reported any risk 
factors  was small. In our study we could not establish a statistically 
significant relationship  between a positive history of predisposing factors and 
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PONV. Some studies have suggested a relationship between  patients  medical 
status and the occurrence of PONV 52,32. Our results did not reach statistical 
significance, as only 2 patients were ASA II . 
INTRAOPERATIVE-RELATED FACTORS 
The etiology of PONV is complex and involves a number of 
interrelated pathways. Intraoperative  and anesthetic factors play a major role 
in its occurrence. The type of surgery is an  independent risk factor for the 
development of  PONV.   In order to analyze surgical site and duration  with 
PONV, we divided the procedures into those performed only in the mandible, 
only in the  maxilla, or both. Our data showed a greater number of emetic 
episodes when the mandible (20%) was involved, with the greatest frequency 
of PONV in the bimaxillary surgery group .A number of explanations  for this 
finding are possible. One explanation may be the greater average length of 
surgery time for  bimaxillary surgeries versus isolated maxillary or mandibular 
surgeries. Unlike previous studies which have shown higher incidence of 
PONV in maxillary surgery , our study showed a higher percentage of PONV 
in isolated  mandibular surgeries. This could be attributed to the longer 
duration of mandibular surgeries.  
Emesis can be initiated by noxious stimuli affecting peripheral 
receptors which indirectly activate vagal afferent fibers and therefore stimulate 
the CTZ.  Blood in the stomach is considered to be one of the strongest 
peripheral emetogenic stimuli. Throatpack in the oropharynx was  placed in all 
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patients  at the beginning of all orthognathic procedures and all patients 
received gastric  suctioning at the end of the procedure. 
Some authors have suggested placing the nasogastric tube at the 
beginning of the surgical procedure  not only to evacuate gastric contents, but 
also to decompress gastric distention that may occur after vigorous 
preoperative mask ventilation. But on contrary  in  some cases  nasogastric 
tube can  even increase the incidence of PONV by stimulating the 
glossopharyngeal nerve. The main role of blood  in the stomach, as an 
important emetic factor, is not well understood. Clinically, we observed that 
those  patients who were experiencing PONV usually noted good  relief of 
their emetic symptoms after expulsion of their gastric contents, especially 
patients who vomited blood clots. 
In our patients it was found that the longer the surgery, the higher the 
incidence of PONV. Sinclair et al 47 found that the prevalence of PONV 
increased from 2.8% in patients whose surgery was less than 30 minutes to 
27.7% in patients with a surgical duration of 150 to 180 minutes. One possible 
explanation for these findings is the greater accumulation of emetogenic 
drugs, specifically those drugs related to the general anesthetic 3. Our results 
were similar, demonstrating an increase of PONV in surgeries longer than 2 
hours. 
Among the anesthetic factors that may influence the incidence of 
PONV, the most commonly defined are: inhalation agents, neuromuscular 
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reversal drugs20, dehydration, hypotension, and the use of prophylactic 
antiemetic drugs. General anesthesia can be provided by IV medications 
and/or inhaled volatile anesthetics1. At our institution, sodium thiopentone for 
induction and halothane 0.5% for maintenance, were the most commonly 
administered anesthetic drugs. 
Although total  IV anesthesia may lead to reduced PONV, it can be 
somewhat difficult to maintain a normotensive or mildly hypotensive mean 
arterial blood pressure, which is desired in maxillary and bimaxillary 
procedures.GA can be provided by IV medication and or inhaled volatile 
anaesthetic (Alessandro C Silva etal 1) Propofol for induction and either 
desflurane or sevoflurane for maintenance  were the most commonly 
administered anaesthetic drugs. They found higher prevalence of PONV in 
patients whom volatile anaesthesia was used 41.48% and the incidence of 
PONV reduced to 14.81% for total IV anaesthesia..  
Apfel et al 3 considered the use of volatile anaesthetics as the main 
cause of early PONV (0-2 hrs), however with no impact on later postoperative 
period (2-24hrs).  
Hofer et al 24 reports the reduction of PONV with total IV General 
anaesthesia alone used  for surgeries of short duration (less than 60 minutes) 
and that involved only the mandible (BSSO). Although total IV anaesthesia 
may lead to reduced PONV it can be somewhat difficult to maintain  
normotensive or mildly hypotensive mean arterial blood pressure which is 
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desired in maxillary and bimaxillary procedures. They are more expensive and 
also requires Opioids or Beta Blockers  for arterial blood pressure control. 
Hence the best approach for rapid recovery with lower incidence of PONV 
seems to be when all three drug types – Volatile inhalation agents, IV 
hypnotics and Opioids  are properly dosed (Betts NJ, Turvey et al 5). 
 The combination of  nitrous oxide   and opioids results in a higher 
frequency of PONV compared to inhalation general anesthetics that did not 
involve nitrous oxde . In our analysis we verified the influence of inhalation 
agents on the incidence  of  PONV. However PONV was significant when 
nitrous oxide was used in combination with halothane 0.5%. Liberal 
intravenous fluid administration and supplemental oxygen therapy have been 
thought to reduce the incidence of PONV. Liberal intravenous fluid infusion 
decreases the amount of oral fluids requested by the patients in the immediate 
postoperative period, thus decreasing gastric upset and subsequent emesis. Our 
patients’ level of hydration was routinely based on the length of the surgical 
procedure and the amount of blood loss. 
Supplemental intraoperative oxygen is also a subject of controversy. 
Some authors have proposed its use for PONV reduction 21,30, but most have 
questioned its efficacy. Because oxygen is inexpensive and essentially risk-
free, supplemental oxygen can and should be used and may be an effective 
tool in avoiding PONV. 
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 Intraoperatively, the inhalation agents were delivered together with 
either oxygen or nitrous oxide/oxygen. Postoperatively, all patients received 
supplemental oxygen during their hospital stay for a minimum of three hours 
till the patient maintains 100% oxygen saturation.  It has been suggested that 
the use of more than one prophylactic antiemetic drug, acting at different 
receptor sites, is more effective than the use of a single drug 22. However, 
antiemetic prophylaxis alone is not the only preventive factor to be considered. 
The literature has suggested that, in high-risk patients, a multimodal approach 
(volatile anesthetic avoidance and antiemetic administration) has shown the 
best results. Apfel et al 11 were the first to identify and define these risk 
factors. They found female gender, smoking status, history of previous PONV 
or motion sickness, and the postoperative use of opioids were the most 
important risk factors associated with PONV. The  emetic prevalence 
increased proportionally with the number of risk factors identified: none 
(10%), 1 (21%), 2 (39%), 3 (61%), or 4 (79%).  
The most common risk factors in our patients were: female gender, 
predisposing PONV factors (history of motion sickness ) surgical site, 
procedure duration, volatile general anesthetic use  and pain level.  The 
assessment of the PONV risk factors in each individual patient  is a foundation 
for evidence-based recommendations for the management of PONV. 
Comparing costs of anesthetic drugs alone (direct costs) is inappropriate, as 
postoperative adverse events such as PONV may be associated with secondary 
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expenses (indirect costs). Thus, identification of risk for adverse outcomes 
appears to be a more efficient and inexpensive way to comprehensively 
manage these patients. 
POSTOPERATIVE-RELATED FACTORS 
NSAIDS are commonly used postoperatively in our orthognathic surgery 
patients. Nausea is frequently accompanied by pain in the early postoperative 
period and the relief of pain  resulted in relief of nausea as well. The basic 
mechanism of pain-induced emesis is still not well understood; however, it has 
been suggested that pain is associated with emesis via activation of the 
sympathetic nervous system. Jenkins  and Lahay 29 first proposed a 
relationship between emesis and increased circulating catecholamines. 
Researchers have emphasized the role of pain as a primary factor in emesis 
initiation. Our results also showed a trend of increased PONV with increasing 
pain level. Our standard protocol for postoperative pain management involves 
administration of intramuscular administration of voveran 3 ml .  Our results 
indicate that pain may be an influencing factor in the occurrence of PONV, but 
this was evaluated only in the PACU.  
Most of our patients experienced PONV within the first 2 hours after 
surgery. We also observed more emetic events when patients experience the 
greatest level of pain and requested pain relief medication.  
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The main goal of this research was to identify the most common 
patient , anesthetic and surgically related risk factors for PONV and develop  
efficient  preventive protocols to this common and unpleasant problem. 
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CONCLUSION 
The prospective data of 25 patients were collected from department of 
oral and maxillofacial surgery, Ragas dental college and hospital , Chennai. 
The age of  patients ranged between 15 to 50 years  with a mean age of 32.5 
years. The incidence of postoperative nausea and vomting was assessed  based 
on following factors:  preanesthetic factors which include  age, sex, previous 
history of motion sickness, habits like smoking  ,preanesthetic  medication, 
ASA status , reaction to prior anesthetics ,history of menstruation or harmone 
therapy.  Intraoperative anesthetic factors which include duration of the 
procedure, type of anesthesia ,inhalation agents used ,neuromuscular blockers, 
IV anesthetics ,antiemetics, reversal drugs, antibiotics and steroids used. 
surgical  factors  include surgical site. Postoperative factors include analgesics 
used antiemetics, pain level . 
The patients were observed in the post anesthetic care unit for signs of 
nausea and vomiting during the the first 24 hours  after the surgical procedure 
under general anesthesia. 
The following conclusions can be derived from this study : 
1. There was difference in postoperative nausea and vomiting with regard 
to age. Patients in young age group between 15 to 20 years showed 
high incidence of PONV compared to other groups. 
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2. Percentage of females with PONV was higher than males . The value 
was statistically not significant. 
3. Only 2 patients were ASA II , of them one patient experienced PONV. 
4. Only one patient had a history of motion sickness and experienced 
PONV. 
5. PONV was high in patients undergoing bimaxillary surgeries 
compared to isolated jaw surgeries. 
6. Incidence PONV increased with duration of the surgery. Longer the 
surgery, higher was the incidence of PONV. 
7. Incidence of PONV was higher when an inhalation agent (halothane) 
was used along with nitrous oxide. 
8. Increase in pain level increased the incidence of PONV. 
Although some risk factors mentioned above have been found to be 
significantly associated with  incidence of postoperative nausea and 
vomiting , further studies are needed with a larger sample size to confirm 
these findings. 
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